Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (34)

Search Parameters:
Keywords = HPT axis

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
26 pages, 1855 KiB  
Article
Effect of a Low-Molecular-Weight Allosteric Agonist of the Thyroid-Stimulating Hormone Receptor on Basal and Thyroliberin-Stimulated Activity of Thyroid System in Diabetic Rats
by Kira V. Derkach, Alena S. Pechalnova, Viktor N. Sorokoumov, Inna I. Zorina, Irina Y. Morina, Elizaveta E. Chernenko, Egor A. Didenko, Irina V. Romanova and Alexander O. Shpakov
Int. J. Mol. Sci. 2025, 26(2), 703; https://doi.org/10.3390/ijms26020703 - 15 Jan 2025
Viewed by 369
Abstract
The approaches to correct thyroid deficiency include replacement therapy with thyroid hormones (THs), but such therapy causes a number of side effects. A possible alternative is thyroid-stimulating hormone (TSH) receptor activators, including allosteric agonists. The aim of this work was to study the [...] Read more.
The approaches to correct thyroid deficiency include replacement therapy with thyroid hormones (THs), but such therapy causes a number of side effects. A possible alternative is thyroid-stimulating hormone (TSH) receptor activators, including allosteric agonists. The aim of this work was to study the effect of ethyl-2-(4-(4-(5-amino-6-(tert-butylcarbamoyl)-2-(methylthio)thieno[2,3-d]pyrimidin-4-yl)phenyl)-1H-1,2,3-triazol-1-yl) acetate (TPY3m), a TSH receptor allosteric agonist developed by us, on basal and thyroliberin (TRH)-stimulated TH levels and the hypothalamic-pituitary-thyroid (HPT) axis in male rats with high-fat diet/low-dose streptozotocin-induced type 2 diabetes mellitus (T2DM). Single and three-day administration of TPY3m (i.p., 20 mg/kg) was studied, and the effect of TPY3m on the HPT axis was compared with that of levothyroxine. TPY3m increased TH levels when administered to both healthy and diabetic rats, normalizing thyroxine and triiodothyronine levels in T2DM and, unlike levothyroxine, without negatively affecting TSH levels or the expression of hypothalamic and pituitary genes responsible for TSH production. TPY3m pretreatment preserved the stimulatory effects of TRH on TH levels and thyroid gene expression. This indicates the absence of competition between TPY3m and endogenous TSH for TSH receptor activation and is supported by our in vitro results on TPY3m- and TSH-stimulated adenylate cyclase activity in rat thyroid membranes. Morphological analysis of thyroid glands in diabetic rats after three-day TPY3m administration shows an increase in its functional activity without destructive changes. To summarize, TPY3m, with the activity of a partial allosteric agonist of the TSH receptor, was created as a prototype of drugs to correct thyroid insufficiency in T2DM. Full article
(This article belongs to the Special Issue Thyroid Hormone and Molecular Endocrinology)
Show Figures

Figure 1

Figure 1
<p>Effect of different concentrations of TPY3m on the basal (<b>A</b>) and TSH-stimulated (<b>B</b>) adenylate cyclase activity in the rat thyroid membranes. (<b>A</b>) The basal AC activity was 19.7 ± 0.8 pmol cAMP/min per mg of membrane protein. Stimulating effects of TPY3m were assessed in the concentration range from 10<sup>−9</sup> to 10<sup>−4</sup> M. (<b>B</b>) The AC activity stimulated by TSH (10<sup>−9</sup> M) was 144.2 ± 4.1 pmol cAMP/min per mg of membrane protein (+632% over the basal AC activity). Combined action of TSH and TPY3m were assessed in the presence of 10<sup>−9</sup>–10<sup>−4</sup> M TPY3m. <sup>a</sup> The differences from the basal AC activity are significant at <span class="html-italic">p</span> &lt; 0.05. <sup>b</sup> The differences from AC activity stimulated by TSH alone (in the absence of TPY3m) are significant at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 2
<p>Effect of treatment with TPY3m (single dose 20 mg/kg, i.p.) on the basal and thyroliberin-stimulated levels of thyroid hormones and TSH in the blood of healthy rats. (<b>A</b>)—fT4, (<b>B</b>)—tT4, (<b>C</b>)—fT3, (<b>D</b>)—tT3, (<b>E</b>)—TSH. Differences with the control (<sup>a</sup>), C + TRH (<sup>b</sup>), and C + TP (<sup>c</sup>) groups are significant at <span class="html-italic">p</span> &lt; 0.05. Data are presented as M ± SEM, and in all groups, <span class="html-italic">n</span> = 6.</p>
Full article ">Figure 3
<p>Effect of single-dose TPY3m administration (20 mg/kg, i.p.) on basal and thyroliberin-stimulated thyroid hormone levels in rats with high-fat diet/low-dose streptozotocin-induced T2DM. (<b>A</b>)—fT4, (<b>B</b>)—tT4, (<b>C</b>)—fT3, (<b>D</b>)—tT3. The differences with the C1 (<sup>a</sup>) and D1 (<sup>b</sup>) groups are significant at <span class="html-italic">p</span> &lt; 0.05. The data on the blood tT4 levels are not normally distributed and are presented as median and interquartile ranges (25%; 75%). The data on the blood levels of fT4, fT3, and tT3 are normally distributed and are presented as M ± SEM. In all groups, <span class="html-italic">n</span> = 6.</p>
Full article ">Figure 4
<p>Effect of three-day treatment with TPY3m and levothyroxine on the blood levels of thyroid hormones and TSH in male rats with T2DM. (<b>A</b>)—fT4, (<b>B</b>)—tT4, (<b>C</b>)—fT3, (<b>D</b>)—tT3, (<b>E</b>)—TSH. Differences with the C2 (<sup>a</sup>), D2 (<sup>b</sup>), and D2 + TP (<sup>c</sup>) groups are significant at <span class="html-italic">p</span> &lt; 0.05. The data on the blood tT4 and TSH levels are not normally distributed and are presented as median and interquartile ranges (25%; 75%). The data on the blood levels of fT4, fT3 and tT3 are normally distributed and are presented as M ± SEM. In all groups, <span class="html-italic">n</span> = 6.</p>
Full article ">Figure 5
<p>Thyroid gland sections from control (C2) and diabetic rats (D2) and diabetic animals treated with TPY3m for three days (D2 + TP). Hematoxylin and eosin staining. Scale bar: 100 μm. A detailed description of the morphological features is given in the text.</p>
Full article ">
14 pages, 3451 KiB  
Article
Effects of 4G Long-Term Evolution Electromagnetic Fields on Thyroid Hormone Dysfunction and Behavioral Changes in Adolescent Male Mice
by Hyun-Yong Kim, Yeonghoon Son, Ye Ji Jeong, Soo-Ho Lee, Nam Kim, Young Hwan Ahn, Sang Bong Jeon, Hyung-Do Choi and Hae-June Lee
Int. J. Mol. Sci. 2024, 25(20), 10875; https://doi.org/10.3390/ijms252010875 - 10 Oct 2024
Viewed by 2058
Abstract
Radiofrequency electromagnetic fields (RF-EMFs) can penetrate tissues and potentially influence endocrine and brain development. Despite increased mobile phone use among children and adolescents, the long-term effects of RF-EMF exposure on brain and endocrine development remain unclear. This study investigated the effects of long-term [...] Read more.
Radiofrequency electromagnetic fields (RF-EMFs) can penetrate tissues and potentially influence endocrine and brain development. Despite increased mobile phone use among children and adolescents, the long-term effects of RF-EMF exposure on brain and endocrine development remain unclear. This study investigated the effects of long-term evolution band (LTE) EMF exposure on thyroid hormone levels, crucial for metabolism, growth, and development. Four-week-old male mice (C57BL/6) were exposed to LTE EMF (whole-body average specific absorption rate [SAR] 4 W/kg) or a positive control (lead; Pb, 300 ppm in drinking water) for 4 weeks. Subsequently, the mice underwent behavioral tests including open field, marble burying, and nest building. Blood pituitary and thyroid hormone levels, and thyroid hormone-regulating genes within the hypothalamus–pituitary–thyroid (HPT) axis were analyzed. LTE exposure increased T3 levels, while Pb exposure elevated T3 and T4 and decreased ACTH levels. The LTE EMF group showed no gene expression alterations in the thyroid and pituitary glands, but hypothalamic Dio2 and Dio3 expressions were significantly reduced compared to that in the sham-exposed group. Pb exposure altered the hypothalamic mRNA levels of Oatp1c1 and Trh, pituitary mRNA of Trhr, and Tpo and Tg expression in the thyroid. In conclusion, LTE EMF exposure altered hypothalamic Dio2 and Dio3 expression, potentially impacting the HPT axis function. Further research is needed to explore RF-EMF’s impacts on the endocrine system. Full article
(This article belongs to the Section Molecular Endocrinology and Metabolism)
Show Figures

Figure 1

Figure 1
<p>Measurement of body weight. All animals subjected to LTE-RF-EMF (LTE) or Pb exposure were weighed weekly for 4 weeks.</p>
Full article ">Figure 2
<p>Evaluation of behavioral changes in the mice exposed to LTE or Pb treatments during adolescence. (<b>A</b>) The representative traces of movement measured in the open-field test. (<b>B</b>) Measured average velocity, distance traveled, and activity and time in the central zone. (<b>C</b>) The results of the marble-burying test with representative photos and quantification in the mice exposed to sham, LTE, or Pb treatments during adolescence. (<b>D</b>) The representative photos and scores of the built nests by the mice exposed to sham, LTE, or Pb treatments during adolescence. The data are presented as mean ± standard deviation (n = 10). * <span class="html-italic">p</span> &lt; 0.05, *** <span class="html-italic">p</span> &lt; 0.001, and **** <span class="html-italic">p</span> &lt; 0.0001 versus sham; <sup>####</sup> <span class="html-italic">p</span> &lt; 0.0001 versus LTE exposure.</p>
Full article ">Figure 3
<p>Analysis of the circulating hormone levels following LTE or Pb exposure during adolescence in the C57BL/6 mice. (<b>A</b>) Thyroid hormones: TSH, T3, and T4. (<b>B</b>) Pituitary hormones: brain-derived neurotrophic factor (BDNF) and adrenocorticotropic hormone (ACTH). (<b>C</b>) The testosterone levels. The data are presented as mean ± standard deviation (n = 7–8). * <span class="html-italic">p</span> &lt; 0.05 versus sham.</p>
Full article ">Figure 4
<p>RT-qPCR analysis of the thyroid hormone-regulating genes in the hypothalamic–pituitary–thyroid (HPT) axis. The relative mRNA expression levels of <span class="html-italic">Trh, Dio2, Dio3</span>, and <span class="html-italic">Oatp1c1</span> in the hypothalamus (<b>A</b>); <span class="html-italic">Trhr</span> and <span class="html-italic">Tshβ</span> in the pituitary gland (<b>B</b>); and <span class="html-italic">Tpo</span> and <span class="html-italic">Tg</span> in the thyroid glands (<b>C</b>). The data are presented as mean ± standard deviation (n = 7–8). * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 versus sham; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 versus LTE exposure.</p>
Full article ">Figure 5
<p>Experimental scheme and in vivo LTE signal exposing chamber. (<b>A</b>) LTE and Pb exposure and experimental procedure. (<b>B</b>) Image of the reverberation chamber and the positioned cages in the chamber.</p>
Full article ">
9 pages, 2217 KiB  
Article
Changes in Central Sensitivity to Thyroid Hormones vs. Urine Iodine during Pregnancy
by Ioannis Ilias, Charalampos Milionis, Maria Alexiou, Ekaterini Michou, Chrysi Karavasili, Evangelia Venaki, Kostas Markou, Irini Mamali and Eftychia Koukkou
Med. Sci. 2024, 12(4), 50; https://doi.org/10.3390/medsci12040050 - 27 Sep 2024
Viewed by 1035
Abstract
Introduction/Aim: Central sensitivity to thyroid hormones refers to the responsiveness of the hypothalamic–pituitary–thyroid (HPT) axis to changes in circulating free thyroxine (fT4). Although dose–response relationships between thyroid hormones per se and urinary iodine (UI) levels have been observed, central sensitivity to thyroid hormones [...] Read more.
Introduction/Aim: Central sensitivity to thyroid hormones refers to the responsiveness of the hypothalamic–pituitary–thyroid (HPT) axis to changes in circulating free thyroxine (fT4). Although dose–response relationships between thyroid hormones per se and urinary iodine (UI) levels have been observed, central sensitivity to thyroid hormones in relation to UI remains unexplored. The aim of the present study was to evaluate central sensitivity to thyroid hormones (by means of the Thyroid Feedback Quantile-based Index [TFQI], which is a calculated measure, based on TSH and fT4, that estimates central sensitivity to thyroid hormones) in pregnancy and to assess whether it differs according to gestational age and/or iodine intake. Materials and Methods: One thousand, one hundred and two blood and urine samples were collected from pregnant women (with a mean age ± SD of 30.4 ± 4.6 years) during singleton pregnancies; women with known/diagnosed thyroid disease were excluded. Specifically, TSH and fT4, anti-thyroid peroxidase antibodies and UI were measured in each trimester and at two months postpartum, while the TFQI was calculated for all the study samples. After the elimination of outliers, statistical analysis was conducted with analysis of variance (ANOVA) for the variables versus time period, while Pearson’s correlation was used to assess the TFQI versus UI. Results: The mean TFQI index ranged from −0.060 (second trimester) to −0.053 (two months postpartum), while the corresponding UI was 137 and 165 μg/L, respectively. The TFQI-UI correlation was marginally negative (Pearson r: −0.323, p: 0.04) and significantly positive (r: +0.368, p: 0.050) for UI values over 250 μg/L, in the first and the second trimesters of pregnancy, respectively. Discussion: The TFQI is a new index reflecting central sensitivity to thyroid hormones. A lower TFQI indicates higher sensitivity to thyroid hormones. In our sample, the TFQI was mainly positively related to iodine intake in the second trimester of pregnancy (following the critical period of organogenesis). Thus, the observed changes in the TFQI may reflect the different ways of the central action of thyroid hormones, according to the phase of pregnancy. These results have the potential to enhance our comprehension of the changes in the HPT axis’ function via variations in central sensitivity to thyroid hormones and its interplay with nutritional iodine status during pregnancy. Full article
Show Figures

Figure 1

Figure 1
<p>A flow chart of the study; TFT: thyroid function tests (and anti-thyroid peroxidase antibodies); UI: urine iodine; TFQI: Thyroid Feedback Quantile-based Index; Q1: first quartile; Q3: third quartile; IQR: inter-quartile range.</p>
Full article ">Figure 2
<p>Scatter plots with ordinary least squares (OLS) regression lines for the TFQI vs. urine iodine (UI) levels up to 250 μg/L (<b>A</b>) and above 250 μg/L (<b>B</b>) during each trimester and the postpartum period (PP). Note: In the postpartum period, only one UI measurement exceeded 250 μg/L, precluding OLS regression for this time period.</p>
Full article ">Figure 2 Cont.
<p>Scatter plots with ordinary least squares (OLS) regression lines for the TFQI vs. urine iodine (UI) levels up to 250 μg/L (<b>A</b>) and above 250 μg/L (<b>B</b>) during each trimester and the postpartum period (PP). Note: In the postpartum period, only one UI measurement exceeded 250 μg/L, precluding OLS regression for this time period.</p>
Full article ">
18 pages, 1413 KiB  
Review
Effects of Insecticide and Herbicides on Thyroid Disturbances in Zebrafish
by Tingting Ma, Xiangji An, Peng Wu, Xiaoli He and Yongming Luo
Toxics 2024, 12(8), 570; https://doi.org/10.3390/toxics12080570 - 3 Aug 2024
Viewed by 1889
Abstract
Thyroid cancer usually begins with thyroid dysfunction and nodules and has become the most common cancer globally, especially in women. Although the causes of thyroid dysfunction are complex, the presence of environmental pollutants, especially certain pesticides as established mutagens, has been widely accepted. [...] Read more.
Thyroid cancer usually begins with thyroid dysfunction and nodules and has become the most common cancer globally, especially in women. Although the causes of thyroid dysfunction are complex, the presence of environmental pollutants, especially certain pesticides as established mutagens, has been widely accepted. Zebrafish (Danio rerio) have similar toxic reactions and signal transduction pathways to humans and are very similar to humans in physiology, development, and metabolic function. Here, the direct toxicity effects and mechanisms of different insecticides and herbicides on zebrafish thyroid functions and indirect toxicity effects originating from thyroid dysfunction were summarized and compared. The overall toxicity of insecticides on the zebrafish thyroid was greater than that of herbicides based on effective concentrations. Penpropathrin and atrazine were more typical thyroid disruptors than other pesticides. Meanwhile, chiral pesticides showed more sophisticated single/combined toxicity effects on both parental and offspring zebrafish. Besides thyroid hormone levels and HPT axis-related gene expression alteration, developmental toxicity, immunotoxicity, and oxidative damage effects were all observed. These data are necessary for understanding the thyroid interference effect of pesticides on humans and for screening for thyroid disruptors in surface water with zebrafish models for the pre-assessment of human health risks and ecological risk control in the future. Full article
(This article belongs to the Special Issue Ecotoxicity Induced by Pesticides Exposure Volume II)
Show Figures

Figure 1

Figure 1
<p>Life cycle of zebrafish (<span class="html-italic">Danio rerio</span>).</p>
Full article ">Figure 2
<p>Mechanisms of insecticides/herbicides on HPT-related zebrafish dysfunction.</p>
Full article ">
11 pages, 463 KiB  
Article
Cytokines and Obstructive Sleep Apnea in Childhood: Study of a Group of Children
by Luana Maria Nosetti, Claudio Tirelli, Franca Marino, Michela Gaiazzi, Lucia Sacchi, Mara De Amici, Fiorella Barocci, Ramona Maio, Marco Cosentino and Luigi Nespoli
Biologics 2024, 4(1), 44-54; https://doi.org/10.3390/biologics4010004 - 1 Feb 2024
Viewed by 1938
Abstract
Introduction: Obstructive Sleep Apnea (OSA) in children is characterized by repeated episodes of partial or complete obstruction of the upper airways that impair normal ventilation and cause hypoxia and sleep disruption. These episodes activate innate and adaptive immunity resulting in the production of [...] Read more.
Introduction: Obstructive Sleep Apnea (OSA) in children is characterized by repeated episodes of partial or complete obstruction of the upper airways that impair normal ventilation and cause hypoxia and sleep disruption. These episodes activate innate and adaptive immunity resulting in the production of proinflammatory cytokines: IL-1β, IL-6, TNF-α, and reactive oxygen species. The hypothalamic–pituitary–adrenal (HPT) axis is also activated with alteration of the circadian rhythm of cortisol synthesis. OSA in children, and even more in adults, induces a systemic inflammatory condition that contributes to the genesis of clinical complications: poor growth, learning disabilities, cardiovascular changes, insulin resistance, and metabolic syndrome. Methods: A total of 42 non-obese children (age 1–15 years) were enrolled among those sent to our sleep center to perform full polysomnography (PSG). After PSG, 6 children did not show OSA (controls), 20 had mild OSA (m OSA), and 16 had medium-severe OSA (MS OSA). In vitro IL-1β, TNF-α, and serum cortisol levels were measured at 2 and 8 am in the analyzed groups. Results: Cortisol levels did not differ between controls and OSA children. At 2 am, there were no differences between controls and OSA in TNF-α production, whereas at 8 am, TNF-α was reduced in MS-OSA. IL-1β production showed no differences between OSA and controls. Conclusions: In our population, only TNF-α production is suppressed in MS-OSA: this might indicate a role of OSA severity in inducing inflammation. In adults, the phenomenon is more pronounced due to the habitual greater severity/duration of OSA, presence of comorbidities (cardiovascular and metabolic), and different immune system function. Full article
(This article belongs to the Section Cytokines and Allied Mediators)
Show Figures

Figure 1

Figure 1
<p>Serum cortisol levels (mg/L) assessed at 2.00 and 8.00 am in controls and OSA patients.</p>
Full article ">
19 pages, 975 KiB  
Review
Can Ashwagandha Benefit the Endocrine System?—A Review
by Michał Wiciński, Anna Fajkiel-Madajczyk, Zuzanna Kurant, Dominik Kurant, Karol Gryczka, Michal Falkowski, Magdalena Wiśniewska, Maciej Słupski, Jakub Ohla and Jan Zabrzyński
Int. J. Mol. Sci. 2023, 24(22), 16513; https://doi.org/10.3390/ijms242216513 - 20 Nov 2023
Cited by 7 | Viewed by 16653
Abstract
Withania somnifera, also known as Ashwagandha, has been used in traditional medicine for thousands of years. Due to the wide range of its activities, there has been interest in its possible beneficial effects on the human body. It is proved that, among [...] Read more.
Withania somnifera, also known as Ashwagandha, has been used in traditional medicine for thousands of years. Due to the wide range of its activities, there has been interest in its possible beneficial effects on the human body. It is proved that, among others, Ashwagandha has anti-stress, anti-inflammatory, antimicrobial, anti-cancer, anti-diabetic, anti-obesity, cardioprotective, and hypolipidemic properties. Particularly interesting are its properties reported in the field of psychiatry and neurology: in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, depression, bipolar disorder, insomnia, anxiety disorders and many others. The aim of this review is to find and summarize the effect that Ashwagandha root extract has on the endocrine system and hormones. The multitude of active substances and the wide hormonal problems faced by modern society sparked our interest in the topic of Ashwagandha’s impact on this system. In this work, we also attempted to draw conclusions as to whether W. somnifera can help normalize the functions of the human endocrine system in the future. The search mainly included research published in the years 2010–2023. The results of the research show that Ashwagandha can have a positive effect on the functioning of the endocrine system, including improving the secretory function of the thyroid gland, normalizing adrenal activity, and multidirectional improvement on functioning of the reproductive system. The main mechanism of action in the latter appears to be based on the hypothalamus–pituitary–adrenal (HPA) axis, as a decrease in cortisol levels and an increase in hormones such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in men were found, which results in stress level reduction and improvement in fertility. In turn, other studies prove that active substances from W. somnifera, acting on the body, cause an increase in the secretion of triiodothyronine (T3) and thyroxine (T4) by the thyroid gland and a subsequent decrease in the level of thyroid-stimulating hormone (TSH) in accordance with the hypothalamus–pituitary–thyroid (HPT) axis. In light of these findings, it is clear that Ashwagandha holds significant promise as a natural remedy for various health concerns, especially those related to the endocrine system. Future research may provide new insights into its mechanisms of action and expand its applications in both traditional and modern medicine. The safety and toxicity of Ashwagandha also remain important issues, which may affect its potential use in specific patient groups. Full article
(This article belongs to the Section Molecular Pharmacology)
Show Figures

Figure 1

Figure 1
<p>Structures of withanolides and withaferin A.</p>
Full article ">Figure 2
<p>Structures of some active substances found in Ashwagandha.</p>
Full article ">Figure 3
<p>Due to its active substances <span class="html-italic">W. somnifera</span> acts through GABAA receptors. It causes increased GnRH release, which results in expanded gonadotropins release. It also reduce cortisol level. These interactions have an influence on stress reduction and improving male fertility.</p>
Full article ">
19 pages, 2988 KiB  
Review
Environmental Endocrinology: Parabens Hazardous Effects on Hypothalamic–Pituitary–Thyroid Axis
by Damáris Barcelos Cunha Azeredo, Denilson de Sousa Anselmo, Paula Soares, Jones Bernardes Graceli, D’Angelo Carlo Magliano and Leandro Miranda-Alves
Int. J. Mol. Sci. 2023, 24(20), 15246; https://doi.org/10.3390/ijms242015246 - 17 Oct 2023
Cited by 14 | Viewed by 4849
Abstract
Parabens are classified as endocrine-disrupting chemicals (EDCs) capable of interfering with the normal functioning of the thyroid, affecting the proper regulation of the biosynthesis of thyroid hormones (THs), which is controlled by the hypothalamic–pituitary–thyroid axis (HPT). Given the crucial role of these hormones [...] Read more.
Parabens are classified as endocrine-disrupting chemicals (EDCs) capable of interfering with the normal functioning of the thyroid, affecting the proper regulation of the biosynthesis of thyroid hormones (THs), which is controlled by the hypothalamic–pituitary–thyroid axis (HPT). Given the crucial role of these hormones in health and the growing evidence of diseases related to thyroid dysfunction, this review looks at the effects of paraben exposure on the thyroid. In this study, we considered research carried out in vitro and in vivo and epidemiological studies published between 1951 and 2023, which demonstrated an association between exposure to parabens and dysfunctions of the HPT axis. In humans, exposure to parabens increases thyroid-stimulating hormone (TSH) levels, while exposure decreases TSH levels in rodents. The effects on THs levels are also poorly described, as well as peripheral metabolism. Regardless, recent studies have shown different actions between different subtypes of parabens on the HPT axis, which allows us to speculate that the mechanism of action of these parabens is different. Furthermore, studies of exposure to parabens are more evident in women than in men. Therefore, future studies are needed to clarify the effects of exposure to parabens and their mechanisms of action on this axis. Full article
(This article belongs to the Topic Environmental Toxicology and Human Health)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Main effects of exposure to parabens on human health [<a href="#B90-ijms-24-15246" class="html-bibr">90</a>,<a href="#B95-ijms-24-15246" class="html-bibr">95</a>,<a href="#B97-ijms-24-15246" class="html-bibr">97</a>,<a href="#B100-ijms-24-15246" class="html-bibr">100</a>]. (<b>A</b>) Effects of paraben exposureduring pregnancy on the HPT axis hormones and maternal and newborn health. (<b>B</b>) Effects of general human exposure to parabens on the HPT axis hormones. Legend: BuP—butylparaben; EP—ethylparaben; MP—methylparaben; PP—propylparaben; TSH—thyroid-stimulating hormone; THs—thyroid hormones; fT4—free thyroxine levels; fT3—free triiodothyronine levels; tT4—total thyroxine levels; tT3—total triiodothyronine levels. This figure was made using the Canva platform.</p>
Full article ">Figure 2
<p>Main effects of exposure to parabens on rodents. Effects of parabens exposure in the HPT axis of female and male rodents. Legend: BuP—butylparaben; IBP—isobutylparaben; IPP—isopropylparaben; PP—propylparaben; TSH—thyroid-stimulating hormone; fT4—free thyroxine levels; fT3—free triiodothyronine levels; tT4—total thyroxine levels; tT3—total triiodothyronine levels. This figure was made using the Canva platform.</p>
Full article ">Figure 3
<p>Main effects of exposure to parabens on vertebrates. (<b>A</b>) Consequences of paraben exposure in zebrafish larvae. The blue arrow indicates the effects of paraben exposure on the larvae’s thyroid gland, resulting in a decrease in thyroid hormones (THs). The studied parabens are listed below the larva in order of toxicity: BuP &gt; PP &gt; EP &gt; MP. (<b>B</b>) Impacts of paraben exposure on tadpoles. On the left side of the image, we can see water with high levels of propylparaben (PP). Tadpoles exposed to parabens in the water experience a significant mortality rate, as shown on the right side of the image. The decrease in PP levels in the water indicates that tadpoles absorb PP from the water, accumulating the substance in their bodies. This figure was made using the Canva platform. Legend: THs—thyroid hormones; BuP—butylparaben; PP—propylparaben; EP—ethylparaben; MP—methylparaben.</p>
Full article ">
31 pages, 2495 KiB  
Review
Hypothalamus and Post-Traumatic Stress Disorder: A Review
by Payman Raise-Abdullahi, Morvarid Meamar, Abbas Ali Vafaei, Maryam Alizadeh, Masoomeh Dadkhah, Sakineh Shafia, Mohadeseh Ghalandari-Shamami, Ramtin Naderian, Seyed Afshin Samaei and Ali Rashidy-Pour
Brain Sci. 2023, 13(7), 1010; https://doi.org/10.3390/brainsci13071010 - 29 Jun 2023
Cited by 23 | Viewed by 11243
Abstract
Humans have lived in a dynamic environment fraught with potential dangers for thousands of years. While fear and stress were crucial for the survival of our ancestors, today, they are mostly considered harmful factors, threatening both our physical and mental health. Trauma is [...] Read more.
Humans have lived in a dynamic environment fraught with potential dangers for thousands of years. While fear and stress were crucial for the survival of our ancestors, today, they are mostly considered harmful factors, threatening both our physical and mental health. Trauma is a highly stressful, often life-threatening event or a series of events, such as sexual assault, war, natural disasters, burns, and car accidents. Trauma can cause pathological metaplasticity, leading to long-lasting behavioral changes and impairing an individual’s ability to cope with future challenges. If an individual is vulnerable, a tremendously traumatic event may result in post-traumatic stress disorder (PTSD). The hypothalamus is critical in initiating hormonal responses to stressful stimuli via the hypothalamic–pituitary–adrenal (HPA) axis. Linked to the prefrontal cortex and limbic structures, especially the amygdala and hippocampus, the hypothalamus acts as a central hub, integrating physiological aspects of the stress response. Consequently, the hypothalamic functions have been attributed to the pathophysiology of PTSD. However, apart from the well-known role of the HPA axis, the hypothalamus may also play different roles in the development of PTSD through other pathways, including the hypothalamic–pituitary–thyroid (HPT) and hypothalamic–pituitary–gonadal (HPG) axes, as well as by secreting growth hormone, prolactin, dopamine, and oxytocin. This review aims to summarize the current evidence regarding the neuroendocrine functions of the hypothalamus, which are correlated with the development of PTSD. A better understanding of the role of the hypothalamus in PTSD could help develop better treatments for this debilitating condition. Full article
(This article belongs to the Special Issue Hypothalamic-Related Disorders)
Show Figures

Figure 1

Figure 1
<p>This figure depicts the hypothalamus’s function following exposure to significant stress or traumatic events. The hypothalamus activates two distinct pathways in response to stress: the ANS (specifically, the sympathetic nervous system) and the HPA axis. The sympathetic nervous system acts faster by releasing noradrenaline and adrenaline from the adrenal medulla, while the HPA axis pathway acts slower by releasing glucocorticoids from the adrenal cortex. CRH, primarily released from the hypothalamus, initiates the HPA axis. Along with AVP, CRH affects the anterior pituitary to release ACTH, which drives the adrenal cortex to produce glucocorticoid hormones such as cortisol in humans and corticosterone in rats, mice, birds, and most reptiles. Dysregulation of the HPA axis is associated with several mental disorders, including PTSD, depression, and schizophrenia. Understanding the complex interplay between the ANS and the HPA axis can provide insight into the physiological response to stress and the development of mental disorders. ANS: the autonomic nervous system; CRH: corticotropin-releasing hormone; HPA: hypothalamic–pituitary–adrenal; AVP: arginine vasopressin; ACTH: adrenocorticotropic hormone; PTSD: post-traumatic stress disorder; NE: norepinephrine, E: epinephrine.</p>
Full article ">Figure 2
<p>This figure depicts the brain regions that secrete CRH. While the hypothalamus is the primary source of CRH, other brain areas also secrete this hormone. CRH binds to its BLA, CRHR1, and CRHR2 receptors in the central amygdala, modulating stress-emotional memories and anxiety. Additionally, CRH is involved in terminating stress-related anxiety. In the locus coeruleus, CRH binds to CRHR1 and interacts with the noradrenaline pathway. In the hippocampus, CRH released by interneurons binds to pyramidal cells CRHR1, affecting stress-related learning and memory. The BnST releases CRH, which modulates stress-related anxiety via CRHR1 located in the nucleus accumbens and CRHR2. Understanding the distribution of CRH and its receptors throughout the brain provides insight into the complex role of this hormone in stress-related behaviors. CRH is a critical component of the HPA axis and plays a crucial role in the body’s response to stress. CRH: corticotropin-releasing hormone, CRHR: corticotropin-releasing hormone receptor. HPA: hypo-thalamic–pituitary–adrenal; CeA: central amygdala; BLA: basolateral amygdala; BnST: bed nucleus of the stria terminalis.</p>
Full article ">Figure 3
<p>This figure illustrates the potential interaction between the ghrelin-GH axis and PTSD. Chronic stress increases ghrelin levels and activates the amygdala’s ghrelin receptors (GHSR1a). The enhanced activity of ghrelin receptors potentiates stress-induced fear memory, independent of the HPA axis activity. The source of ghrelin that modulates fear is not yet clear, as ghrelin is synthesized mainly in the stomach and released to a lesser extent by the small intestine, pancreas, lungs, kidney, hypothalamus, cerebral cortex, and brainstem. While peripherally-derived ghrelin appears to play a dominant role in fear memory, centrally-derived ghrelin may also contribute to this process. Ghrelin stimulates GH secretion by activating GHSR in the hypothalamus and pituitary gland. GH is a major downstream effector of ghrelin receptor activation and is increased in the amygdala following chronic stress. The joint action of ghrelin and GH in the amygdala leads to a significant increase in fear and may promote the development of PTSD. Understanding the complex interaction between the ghrelin-GH axis and PTSD may provide insight into the underlying mechanisms of this disorder and may lead to the development of more effective treatments. GH: growth hormone, GHSR: growth hormone secretagogue receptors, GHRH: growth hormone-releasing hormone, GHSR1a: growth hormone secretagogue receptor 1a, PTSD: post-traumatic stress disorder.</p>
Full article ">Figure 4
<p>This figure illustrates the complex interactions between the HPA and HPG axes. In the HPA axis, CRH neurons in the hypothalamus’s PVN secrete CRH, stimulating corticotroph cells in the anterior pituitary to produce ACTH. ACTH affects the adrenal gland to produce cortisol in humans and corticosterone in rodents (right side of the picture). These hormones, via a negative feedback mechanism, prevent corticotrophs and PVN from secreting ACTH and CRH, respectively (not shown). In the HPG axis, GnRH neurons in the POA of the hypothalamus secrete GnRH, which stimulates gonadotroph cells in the anterior pituitary to produce LH and FSH. These hormones affect the gonadal glands, including the testes and ovaries, to produce gonadal steroid hormones such as testosterone, estrogen, and progesterone. Through a negative feedback mechanism, these hormones prevent the POA from secreting GnRH and gonadotrophs from secreting FSH and LH (left side of the picture). In stress conditions, the HPA axis exerts inhibitory effects on the HPG axis. Cortisol inhibits GnRH neurons in the hypothalamus, LH and FSH secretions of the pituitary gland, and the secretion of gonadal steroid hormones. In this inhibitory effect of the HPA axis, CRH also prevents GnRH secretion. The HPG axis can also modulate the HPA axis. Gonadal steroid hormones, such as testosterone, estrogen, and progesterone, inhibit CRH secretion by affecting the PVN of the hypothalamus and ACTH secretion by affecting the corticotrophs of the pituitary gland. Understanding the complex interactions between the HPA and HPG axes is crucial for understanding the physiological response to stress and regulating reproductive function. Blue lines show excitatory pathways, green dashed lines show the inhibitory effects of the HPA axis on the HPG axis, and red dashed lines show the inhibitory effects of the HPG axis on the HPA axis. HPA axis: hypothalamic–pituitary–adrenal axis; HPG axis: hypothalamic–pituitary–gonadal axis; CRH: corticotropin-releasing hormone; PVN: paraventricular nucleus; ACTH: adrenocorticotropic hormone; GnRH: gonadotropin-releasing hormone; POA: preoptic area; LH: luteinizing hormone; FSH: follicle-stimulating hormone.</p>
Full article ">Figure 5
<p>This figure provides an overview of the complex interplay between various neuroendocrine functions of the hypothalamus and stress-related disorders, focusing on PTSD. The figure highlights the involvement of possible dysregulated pathways and key hormones such as ACTH, TSH, FSH, LH, GH, testosterone, estradiol, and progesterone, which are critical for understanding the underlying mechanisms of PTSD and other stress/trauma-related disorders. PTSD: post-traumatic stress disorder; ACTH: adrenocorticotropic hormone; TSH: thyroid-stimulating hormone; FSH: follicle-stimulating hormone; LH: luteinizing hormone; GH: growth hormone; T: testosterone; E2: estradiol; P4: progesterone.</p>
Full article ">
10 pages, 2832 KiB  
Communication
The Evolutions of Microstructure, Texture and Hardness of A1050 Deformed by HPT at the Transition Area
by Hongjun Ni, Chenchen Ding, Haoyu Wang, Shuaishuai Lv, Xingxing Wang and Yu Liu
Materials 2023, 16(13), 4686; https://doi.org/10.3390/ma16134686 - 29 Jun 2023
Cited by 4 | Viewed by 1208
Abstract
High-pressure torsion (HPT) is an effective severe plastic deformation method to produce ultrafine-grained (UFG) and nanocrystalline (NC) materials. In the past, most studies have focused on the evolutions in the microstructure, texture and mechanical properties of HPT-deformed materials at peripheral regions. The corresponding [...] Read more.
High-pressure torsion (HPT) is an effective severe plastic deformation method to produce ultrafine-grained (UFG) and nanocrystalline (NC) materials. In the past, most studies have focused on the evolutions in the microstructure, texture and mechanical properties of HPT-deformed materials at peripheral regions. The corresponding evolutions at a special area were observed in this study to reveal the potential plastic deformation mechanism for face-centred cubic (FCC) material with high stacking fault energy. A decreasing trend was found in grain size, and the final grain size was less than 1 μm. However, close observation revealed that the general trend could be divided into different sub-stages, in which grain elongation and grain fragmentation were dominant, respectively. Additionally, microhardness demonstrated a non-linear increase with the development of plastic deformation. Finally, the microhardness reached a high level of ~64 HV. At the early stages of HPT, the C component was transformed into a cube component, suggesting the material flows around the shear plane normal (SPN) axis at these stages. However, finally they will be replaced by ideal simple shear orientations. Full article
Show Figures

Figure 1

Figure 1
<p>The HPT experiment of A1050. (<b>a</b>) The HPT equipment; (<b>b</b>) the schematic diagram of HPT experiment; (<b>c</b>) the HPT-deformed sample; (<b>d</b>) the schematic diagram of hardness testing and EBSD scanning area, and the sample reference system.</p>
Full article ">Figure 2
<p>IPF-coloured EBSD maps of samples subjected to different torsional strains: (<b>a</b>) 0.00, (<b>b</b>) 0.21, (<b>c</b>) 0.42, (<b>d</b>) 1.27, (<b>e</b>) 2.54, (<b>f</b>) 5.08, (<b>g</b>) 10.16, (<b>h</b>) 15.24 and (<b>i</b>) 25.40.</p>
Full article ">Figure 3
<p>(<b>a</b>) The grain size and (<b>b</b>) aspect ratio of samples subjected to different torsional strains.</p>
Full article ">Figure 4
<p>The fraction of low-angle grain boundary and high-angle grain boundary.</p>
Full article ">Figure 5
<p>Microhardness of testing areas in the samples deformed by different equivalent strains.</p>
Full article ">Figure 6
<p>The ϕ2 = 45° ODF maps of samples subjected to different torsional strains: (<b>a</b>) 0.00, (<b>b</b>) 0.21, (<b>c</b>) 0.42, (<b>d</b>) 1.27, (<b>e</b>) 2.54, (<b>f</b>) 5.08, (<b>g</b>) 10.16, (<b>h</b>) 15.24 and (<b>i</b>) 25.40.</p>
Full article ">
17 pages, 576 KiB  
Article
Automatic Levothyroxine Dosing Algorithm for Patients Suffering from Hashimoto’s Thyroiditis
by Ravi Sharma, Verena Theiler-Schwetz, Christian Trummer, Stefan Pilz and Markus Reichhartinger
Bioengineering 2023, 10(6), 724; https://doi.org/10.3390/bioengineering10060724 - 14 Jun 2023
Cited by 3 | Viewed by 1971
Abstract
Hypothyroidism is a condition where the patient’s thyroid gland cannot produce sufficient thyroid hormones (mainly triiodothyronine and thyroxine). The primary cause of hypothyroidism is autoimmune-mediated destruction of the thyroid gland, referred to as Hashimoto’s thyroiditis. A patient’s desired thyroid hormone concentration is achieved [...] Read more.
Hypothyroidism is a condition where the patient’s thyroid gland cannot produce sufficient thyroid hormones (mainly triiodothyronine and thyroxine). The primary cause of hypothyroidism is autoimmune-mediated destruction of the thyroid gland, referred to as Hashimoto’s thyroiditis. A patient’s desired thyroid hormone concentration is achieved by oral administration of thyroid hormone, usually levothyroxine. Establishing individual levothyroxine doses to achieve desired thyroid hormone concentrations requires several patient visits. Additionally, clear guidance for the dosing regimen is lacking, and significant inter-individual differences exist. This study aims to design a digital automatic dosing algorithm for patients suffering from Hashimoto’s thyroiditis. The dynamic behaviour of the relevant thyroid function is mathematically modelled. Methods of automatic control are exploited for the design of the proposed robust model-based levothyroxine dosing algorithm. Numerical simulations are performed to evaluate the mathematical model and the dosing algorithm. With the help of the developed controller thyroid hormone concentrations of patients, emulated using Thyrosim, have been regulated under the euthyroid state. The proposed concept demonstrates reliable responses amidst varying patient parameters. Our developed model provides a useful basis for the design of automatic levothyroxine dosing algorithms. The proposed robust feedback loop contributes to the first results for computer-assisted thyroid dosing algorithms. Full article
(This article belongs to the Section Biosignal Processing)
Show Figures

Figure 1

Figure 1
<p>Block diagram of hypothalamic–pituitary–thyroid axis (HPT axis), explaining thyroid hormone regulation in the human body.</p>
Full article ">Figure 2
<p>For parameter identification, both models receive the same amount of <math display="inline"><semantics> <mrow> <mi>L</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> dosage.</p>
Full article ">Figure 3
<p>Numerical simulation is used for parameter identification. The same amount of dosage is provided to the proposed model and Thyrosim. A comparison between the two generated outputs (<math display="inline"><semantics> <mrow> <mi>F</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> concentration generated by Thyrosim and proposed model) is represented.</p>
Full article ">Figure 4
<p>Sketch of the proposed rate limiter to control the rate of change in recommended dosage.</p>
Full article ">Figure 5
<p>Block diagram of the designed feedback loop including saturator and rate limiter.</p>
Full article ">Figure 6
<p>Robust stability analysis of system with Jury, Pavlidis theorem.</p>
Full article ">Figure 7
<p>Structure of the implemented simulation setup for evaluating the designed dosing algorithm.</p>
Full article ">Figure 8
<p>Thyrosim <math display="inline"><semantics> <mrow> <mi>F</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> concentration is regulated by the developed automated dosage recommendation system (reference <math display="inline"><semantics> <mrow> <mi>F</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> concentration 13 ng/L), simulation time of 12 months.</p>
Full article ">Figure 9
<p>The <math display="inline"><semantics> <mrow> <mi>F</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> concentration of the patient simulated by the Thyrosim is regulated by the developed automated dosage recommendation system (reference <math display="inline"><semantics> <mrow> <mi>F</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> concentration 16 ng/L for the first 18 months and for the last 18 months, the reference <math display="inline"><semantics> <mrow> <mi>F</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> concentration is 12 ng/L).</p>
Full article ">Figure 10
<p>With the help of parameter variation in Thyrosim’s model, 50 patients are simulated. The developed automated dosage recommendation system is used to treat the patients. The mean and standard deviation of the patients’ <math display="inline"><semantics> <mrow> <mi>F</mi> <msub> <mi>T</mi> <mn>4</mn> </msub> </mrow> </semantics></math> levels, as well as the recommended dosage, are presented.</p>
Full article ">
20 pages, 2869 KiB  
Article
Effects of Intermittent Fasting on Hypothalamus–Pituitary–Thyroid Axis, Palatable Food Intake, and Body Weight in Stressed Rats
by Cinthia García-Luna, Ixchel Prieto, Paulina Soberanes-Chávez, Elena Alvarez-Salas, Iván Torre-Villalvazo, Gilberto Matamoros-Trejo and Patricia de Gortari
Nutrients 2023, 15(5), 1164; https://doi.org/10.3390/nu15051164 - 25 Feb 2023
Cited by 5 | Viewed by 3228
Abstract
Dietary regimens that are focused on diminishing total caloric intake and restricting palatable food ingestion are the most common strategies for weight control. However, restrictive diet therapies have low adherence rates in obese patients, particularly in stressed individuals. Moreover, food restriction downregulates the [...] Read more.
Dietary regimens that are focused on diminishing total caloric intake and restricting palatable food ingestion are the most common strategies for weight control. However, restrictive diet therapies have low adherence rates in obese patients, particularly in stressed individuals. Moreover, food restriction downregulates the hypothalamic–pituitary–thyroid axis (HPT) function, hindering weight loss. Intermittent fasting (IF) has emerged as an option to treat obesity. We compared the effects of IF to an all-day feeding schedule on palatable diet (PD)-stress (S)-induced hyperphagia, HPT axis function, accumbal thyrotropin-releasing hormone (TRH), and dopamine D2 receptor expression in association with adipocyte size and PPARƔ coactivator 1α (PGC1α) and uncoupling protein 1 (UCP1) expression in stressed vs. non-stressed rats. After 5 weeks, S-PD rats showed an increased energy intake and adipocyte size, fewer beige cells, and HPT axis deceleration-associated low PGC1α and UCP1 expression, as well as decreased accumbal TRH and D2 expression. Interestingly, IF reversed those parameters to control values and increased the number of beige adipocytes, UCP1, and PGC1α mRNAs, which may favor a greater energy expenditure and a reduced body weight, even in stressed rats. Our results showed that IF modulated the limbic dopaminergic and TRHergic systems that regulate feeding and HPT axis function, which controls the metabolic rate, supporting this regimen as a suitable non-pharmacologic strategy to treat obesity, even in stressed individuals. Full article
(This article belongs to the Special Issue The Intervention of Diet on Energy Metabolism)
Show Figures

Figure 1

Figure 1
<p>Experimental design. Feeding schedule of control (C, pair-housed) and stressed (S, single-housed) adult male rats. C and S rats had <span class="html-italic">ad libitum</span> access to chow (CD) or palatable diet (PD, chocolate milk) for 2 weeks. Once that time elapsed, all CD-fed and half of the PD-fed animals (C-CD-2w, S-CD-2w, C-PD-2w, and S-PD-2w) were euthanized. The remaining C-PD and S-PD rats were divided and subjected to two different feeding schedules: intermittent fasting (IF: feeding window of 8 h (9:00–17:00) during the activity phase: C-IF, S-IF) or fed all day for 3 more weeks. Rats fed all day with a PD had a cumulative intake time of 5 weeks (C-PD-5w, S-PD-5w). At the end of the 5th week, all animals were euthanized.</p>
Full article ">Figure 2
<p>Effect of stress and a palatable diet on body weight and energy intake. (<b>A</b>) Body weight (b.w.) gain of the control (C) or stressed (S) rats fed a regular chow diet (CD) or palatable diet (PD, chocolate milk ingestion) for 2 weeks (C-CD-2w, S-CD-2w, C-PD-2w, and S-PD-2w), n = 6 rats/group in C-CD-2w and S-CD-2w; n = 20 rats/group in C-PD-2w and S-PD-2w. (<b>B</b>) Chow energy intake, (<b>C</b>) Palatable diet energy intake, and (<b>D</b>) Total energy intake (Kcal/Kg b.w.), n = 3 cages/group in C-CD-2w and S-CD-2w; n = 10 cages/group in C-PD-2w and S-PD-2w. Values are the mean ± SEM. *** <span class="html-italic">p</span> &lt; 0.001 vs. C-CD-2w; <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. S-CD-2w, <sup>+</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>+++</sup> <span class="html-italic">p</span> &lt; 0.001 vs. C-PD-2w.</p>
Full article ">Figure 3
<p>Effect of stress and palatable diet intake on neuroendocrine and limbic parameters. (<b>A</b>) TRH mRNA expression in the hypothalamic paraventricular nucleus (PVN), (n = 3–4 rats/group). (<b>B</b>) Serum corticosterone levels, (n = 3–6 rats/group). (<b>C</b>) TRH mRNA expression in the nucleus accumbens (NAc), (n = 3–4 rats/group). (<b>D</b>) Dopamine receptor type 2 (D2) content in the NAc., (n = 3–4 rats/group). Data represent the mean ± SEM of mRNA levels expressed as arbitrary units (<b>A</b>,<b>C</b>), ng/mL (<b>B</b>), and optical density arbitrary units (<b>D</b>). U.D.: undetectable. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. C-CD-2w; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. S-CD-2w.</p>
Full article ">Figure 4
<p>Effect of stress and intermittent fasting on rats fed with a palatable diet. (<b>A</b>) Body weight gain of the control or stressed animals fed with a PD and subjected to two feeding schedules: food available all day (with a cumulative intake time of 5 weeks, C-PD-5w, S-PD-5w) or intermittent fasting (C-IF, S-IF) for 3 additional weeks. Data are represented as the mean ± SEM of grams of b.w. (n = 8 rats/group); (<b>B</b>) Chow energy intake; (<b>C</b>) Palatable diet energy intake; and (<b>D</b>) Total energy intake (Kcal/Kg b.w; n = 4 cages/group. Data represent the mean ± SEM. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. C-PD-5w; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. S-PD-5w.</p>
Full article ">Figure 5
<p>Effect of stress and intermittent fasting on adipose tissue morphology and thermogenesis parameters. (<b>A</b>) Representative photomicrographs of hematoxylin and eosin (H&amp;E) and UCP1 immunostaining of mesenteric white adipose tissue (WAT) at 20X magnification of the control or stressed animals fed with a PD and subjected to two feeding schedules: food available all day (with a cumulative intake time of 5 weeks, C-PD-5w, S-PD-5w) or intermittent fasting (C-IF, S-IF) for 3 additional weeks. Scale bar 100 µm. (<b>B</b>) Mesenteric adipocytes’ size. Data are represented as the mean ± SEM of µm<sup>2</sup>. (<b>C</b>) Number of beige adipocytes per field analyzed. Data are represented as the mean ± SEM of the total number of adipocytes/field. (<b>D</b>) UCP1 and (<b>E</b>) PGC1α mRNA expression in the WAT. Values are the mean ± SEM of the relative abundance of mRNA levels expressed in arbitrary units. n = 4 rats/group. *** <span class="html-italic">p</span> &lt; 0.001 vs. C-PD-5w; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. S-PD-5w; <sup>+</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>++</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>+++</sup> <span class="html-italic">p</span> &lt; 0.0001 vs. C-IF.</p>
Full article ">Figure 6
<p>Effect of stress and intermittent fasting on neuroendocrine parameters. (<b>A</b>) TRH mRNA expression in the hypothalamic paraventricular nucleus (PVN) and (<b>B</b>) NPY mRNA expression in the hypothalamic arcuate nucleus (ARC) of the control or stressed animals fed with a PD and subjected to two feeding schedules: food available all day (with a cumulative intake time of 5 weeks, C-PD-5w, S-PD-5w) or intermittent fasting (C-IF, S-IF) for 3 additional weeks. Values are the mean ± SEM of the mRNA levels expressed in % of difference vs. C-PD-5w (n = 4 rats/group). (<b>C</b>) Corticosterone and (<b>D</b>) T<sub>3</sub> serum levels expressed as ng/mL. Data are the mean ± SEM (n = 4 rats/group). ** <span class="html-italic">p</span> &lt; 0.01 vs. C-PD-5w; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. S-PD-5w; <sup>+</sup> <span class="html-italic">p</span> &lt; 0.05 vs. C-IF.</p>
Full article ">Figure 7
<p>Effect of stress and intermittent fasting on limbic parameters. (<b>A</b>) TRH mRNA expression and (<b>B</b>) dopamine receptor type 2 (D2) content in the nucleus accumbens (NAc) of the control or stressed animals fed with a PD and subjected to two feeding schedules: food available all day (with a cumulative intake time of 5 weeks, C-PD-5w, S-PD-5w) or intermittent fasting (C-IF, S-IF) for 3 additional weeks. Data are expressed as the mean ± SEM expressed in % of difference vs. C-PD-5w, or in arbitrary units of the intensity of D2/actin signals (n = 4 rats/group). ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. C-PD-5w; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. S-PD-5w.</p>
Full article ">
22 pages, 10961 KiB  
Article
Cardamom (Elettaria cardamomum (L.) Maton) Seeds Intake Increases Energy Expenditure and Reduces Fat Mass in Mice by Modulating Neural Circuits That Regulate Adipose Tissue Lipolysis and Mitochondrial Oxidative Metabolism in Liver and Skeletal Muscle
by Claudia Delgadillo-Puga, Ivan Torre-Villalvazo, Yonatan Y. Cariño-Cervantes, Cinthia García-Luna, Paulina Soberanes-Chávez, Patricia de Gortari, Lilia G. Noriega, Claudia J. Bautista and Luis Cisneros-Zevallos
Int. J. Mol. Sci. 2023, 24(4), 3909; https://doi.org/10.3390/ijms24043909 - 15 Feb 2023
Cited by 3 | Viewed by 12098
Abstract
Cardamom seed (Elettaria cardamomum (L.) Maton; EC) is consumed in several countries worldwide and is considered a nutraceutical spice since it exerts antioxidant, anti-inflammatory, and metabolic activities. In obese individuals, EC intake also favors weight loss. However, the mechanism for these effects [...] Read more.
Cardamom seed (Elettaria cardamomum (L.) Maton; EC) is consumed in several countries worldwide and is considered a nutraceutical spice since it exerts antioxidant, anti-inflammatory, and metabolic activities. In obese individuals, EC intake also favors weight loss. However, the mechanism for these effects has not been studied. Here, we identified that EC modulates the neuroendocrine axis that regulates food intake, body weight, mitochondrial activity, and energy expenditure in mice. We fed C57BL/6 mice with diets containing 3%, 6%, or 12% EC or a control diet for 14 weeks. Mice fed the EC-containing diets gained less weight than control, despite slightly higher food intake. The lower final weight of EC-fed mice was due to lesser fat content but increased lean mass than control. EC intake increased lipolysis in subcutaneous adipose tissue, and reduced adipocyte size in subcutaneous, visceral, and brown adipose tissues. EC intake also prevented lipid droplet accumulation and increased mitochondrial content in skeletal muscle and liver. Accordingly, fasting and postprandial oxygen consumption, as well as fasting fat oxidation and postprandial glucose utilization were higher in mice fed with EC than in control. EC intake reduced proopiomelanocortin (POMC) mRNA content in the hypothalamic arcuate nucleus, without an impact on neuropeptide Y (NPY) mRNA. These neuropeptides control food intake but also influence the hypothalamic-pituitary-thyroid (HPT) and hypothalamic-pituitary-adrenal (HPA) axes. Thyrotropin-releasing hormone (TRH) mRNA expression in the hypothalamic paraventricular nucleus (PVN) and circulating triiodothyronine (T3) were lower in EC-fed mice than in control. This effect was linked with decreased circulating corticosterone and weight of adrenal glands. Our results indicate that EC modulates appetite, increases lipolysis in adipose tissue and mitochondrial oxidative metabolism in liver and skeletal muscle, leading to increased energy expenditure and lower body fat mass. These metabolic effects were ascribable to the modulation of the HPT and HPA axes. LC-MS profiling of EC found 11 phenolic compounds among which protocatechuic acid (23.8%), caffeic acid (21.06%) and syringic acid (29.25%) were the most abundant, while GC-MS profiling showed 16 terpenoids among which costunolide (68.11%), ambrial (5.3%) and cis-α-terpineol (7.99%) were identified. Extrapolation of mice-to-human EC intake was performed using the body surface area normalization equation which gave a conversion equivalent daily human intake dose of 76.9–308.4 mg bioactives for an adult of 60 kg that can be obtained from 14.5–58.3 g of cardamom seeds (18.5–74.2 g cardamom pods). These results support further exploration of EC as a coadjuvant in clinical practice. Full article
(This article belongs to the Special Issue Natural Products and Obesity)
Show Figures

Figure 1

Figure 1
<p>Phenolic and terpenoid profiles of cardamom seeds: (<b>A</b>) LC chromatograms of a methanolic extract of cardamom seed and peak assignment in blue of the identified phenolic compounds presented in <a href="#ijms-24-03909-t001" class="html-table">Table 1</a>; (<b>B</b>) GC-MS profiles of volatile compounds of cardamom seeds obtained by steam distillation and peak assignment in red of the identified volatile compounds presented in <a href="#ijms-24-03909-t002" class="html-table">Table 2</a>.</p>
Full article ">Figure 1 Cont.
<p>Phenolic and terpenoid profiles of cardamom seeds: (<b>A</b>) LC chromatograms of a methanolic extract of cardamom seed and peak assignment in blue of the identified phenolic compounds presented in <a href="#ijms-24-03909-t001" class="html-table">Table 1</a>; (<b>B</b>) GC-MS profiles of volatile compounds of cardamom seeds obtained by steam distillation and peak assignment in red of the identified volatile compounds presented in <a href="#ijms-24-03909-t002" class="html-table">Table 2</a>.</p>
Full article ">Figure 2
<p>Body weight gain, food intake and body composition of mice fed a control diet or a diet containing 3%, 6% or 12% of <span class="html-italic">Elettaria cardamomum</span> (EC). (<b>A</b>) body weight in grams from 0–14 weeks one way repeated measures ANOVA; (<b>B</b>) final body weight in grams at week 14; (<b>C</b>) mean daily food intake; (<b>D</b>) mean daily energy intake in calories; (<b>E</b>) percentage of fat mass; and (<b>F</b>) lean mass of mice fed with control diet or a diet containing 3%, 6% or 12% cardamom. Data are presented as the mean ± S.E.M., <span class="html-italic">n</span> = 8 mice per group. The differences were considered statistically significant when <span class="html-italic">p</span> &lt; 0.05. Mean values with different lowercase letters show statistical differences between each other.</p>
Full article ">Figure 3
<p>Adipose tissues morphology, histological analyses, UCP-1 and HSL protein content of mice fed a control diet or a diet containing 3%, 6% or 12% of <span class="html-italic">Elettaria cardamomum</span> (EC). (<b>A</b>) hematoxylin and eosin staining of subcutaneous (SAT), visceral (VAT) and brown adipose tissues (BAT); (<b>B</b>) SAT mean adipocyte size; (<b>C</b>) SAT adipocyte frequency distribution; (<b>D</b>) VAT mean adipocyte size; (<b>E</b>) VAT adipocyte frequency distribution; (<b>F</b>) BAT lipid droplets frequency distribution; (<b>G</b>) BAT lipid droplets frequency distribution; (<b>H</b>) WB images of total HSL, phospho HSL and GAPDH content in SAT, and UCP-1 and GAPDH in BAT; (<b>I</b>) phospho-HSL/total HSL protein abundance ratio; and (<b>J</b>) UCP1/GAPDH protein abundance ratio of mice fed a control diet or a diet containing 3%, 6% or 12% EC. Data are expressed as the mean ± S.E.M., <span class="html-italic">n</span> = 8 mice per group. The differences were considered statistically significant when <span class="html-italic">p</span> &lt; 0.05. Mean values with different lowercase letters show statistical differences between each other. Digital photographs were taken from each section at 20×.</p>
Full article ">Figure 4
<p>Skeletal muscle mitochondrial activity, lipid content, PGC1α and AMPK protein density of mice fed a control diet or a diet containing 3%, 6% or 12% of <span class="html-italic">Elettaria cardamomum</span> (EC). (<b>A</b>) representative photomicrographs of succinate dehydrogenase (SDH) and oil red O (ORO) staining in the skeletal muscle; (<b>B</b>) SDH staining densitometric analysis; (<b>C</b>) ORO staining densitometric analysis; (<b>D</b>) representative image of PGC-1α and AMPK immunoblot; (<b>E</b>) densitometric analysis of AMPK/GADPH protein abundance ratio; and (<b>F</b>) densitometric analysis of PGC1α/GADPH protein abundance ratio of mice fed a control diet or diets containing 3%, 6% or 12% EC. Results are presented as the mean ± S.E.M., <span class="html-italic">n</span> = 8 mice per group. The differences were considered statistically significant when <span class="html-italic">p</span> &lt; 0.05. Mean values with different lowercase letters show statistical differences between each other. Digital photographs were taken from each section at 20×.</p>
Full article ">Figure 5
<p>Liver morphology and hepatic SDH activity of mice fed a control diet or a diet containing 3%, 6% or 12% of <span class="html-italic">Elettaria cardamomum</span> (EC). (<b>A</b>) representative photomicrographs were taken from each section at 40× of hematoxylin and eosin (H&amp;E) and succinate dehydrogenase (SDH) staining in the liver; (<b>B</b>) lipid droplets’ mean area; and (<b>C</b>) SDH densitometry as (%) of liver sections of mice fed a control diet or a diet containing 3%, 6% or 12% EC. Results are presented as the mean ± S.E.M., <span class="html-italic">n</span> = 8 mice per group. The differences were considered statistically significant when <span class="html-italic">p</span> &lt; 0.05. Mean values with different lowercase letters show statistical differences between each other. Digital photographs were taken from each section at 40×.</p>
Full article ">Figure 6
<p>Energy expenditure and substrate oxidation of mice fed a control diet or a diet containing 3%, 6% or 12% of <span class="html-italic">Elettaria cardamomum</span> (EC). (<b>A</b>) Oxygen consumption (VO<sub>2</sub>) during fasting and feeding periods determined by indirect calorimetry analysis; clear and shaded zones indicate fasting and feeding periods, respectively. Average oxygen consumption during (<b>B</b>) fasting and (<b>C</b>) feeding. (<b>D</b>) Respiratory exchange ratio (RER) and average RER during (<b>E</b>) fasting and (<b>F</b>) feeding periods of mice fed a control diet or a diet containing 3%, 6% or 12% EC. Data are presented as the mean ± S.E.M., <span class="html-italic">n</span> = 8 mice per group. The differences were considered statistically significant when <span class="html-italic">p</span> &lt; 0.05. Mean values with different lowercase letters show statistical differences between each other.</p>
Full article ">Figure 7
<p>Hypothalamic peptide gene expression and circulating triiodothyronine (T<sub>3</sub>) and corticosterone concentration of mice fed a control diet or a diet containing 3%, 6% or 12% of <span class="html-italic">Elettaria cardamomum</span> (EC). (<b>A</b>) ARC NPY mRNA and (<b>B</b>) ARC POMC mRNA content, (<b>C</b>) PVN TRH mRNA expression, (<b>D</b>) circulating T<sub>3</sub> levels, (<b>E</b>) adrenal glands’ weight and (<b>F</b>) circulating corticosterone content in mice fed a control diet or a diet containing different concentrations of EC (3%, 6% or 12%) for 14 weeks. Results are presented as the mean ± S.E.M., <span class="html-italic">n</span> = 4–8 mice per group. Mean values with different lowercase letters show statistical differences between each other. One-way ANOVA showed a significant effect of diet: (<b>B</b>) F<sub>(3,15)</sub> = 5.218, <span class="html-italic">p</span> &lt; 0.05, (<b>C</b>) F<sub>(3,26)</sub> = 4.398, <span class="html-italic">p</span> &lt; 0.05, and (<b>E</b>) F<sub>(3,22)</sub> = 6.335, <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 8
<p>Scenario 1: Parallel central and peripheral effects of cardamom intake regulating energy metabolism. The different compounds present in cardamom seeds exerted central and peripheral effects modulating energy balance in mice. Central effects include the modulation of NPY and POMC expression, the hypothalamic peptides controlling food intake and energy expenditure, probably by activation of the GABA<sub>A</sub> receptor. The activity of the TRH and CRH neurons in the paraventricular nucleus (PVN) are also modulated by GABA<sub>A</sub> receptors. These neurons regulate the circulating levels of triiodothyronine (T<sub>3</sub>) and corticosterone. The metabolic activities of T<sub>3</sub> in peripheral tissues include the activation of uncoupling protein 1 (UCP-1) mediated thermogenesis in brown adipose tissue. Cardamom seeds also exerted peripheral effects in adipose tissue, skeletal muscle and the liver, in part by increasing AMP-activated protein kinase (AMPK). AMPK signaling in adipose tissue increased lipolysis by activation of hormone sensitive lipase (HSL). In skeletal muscle and liver, AMPK increases oxidative capacity by increasing mitochondrial biogenesis and activity. Conversely, chronic corticosterone signaling impairs mitochondrial biogenesis and function. Thus, the reduction in circulating corticosterone by cardamom consumption favors oxidative metabolism in metabolic tissues, reducing body fat by increasing lipolysis and whole-body energy expenditure through augmented mitochondrial activity in skeletal muscle and liver. Upwards arrow = upregulation, downwards arrow = downregulation.</p>
Full article ">Figure 9
<p>Scenario 2: Modulation of the thyroid and adrenal axes by cardamom intake, generating an “adjusted hormonal milieu” with peripheral effects regulating energy metabolism. Cardamom seed consumption modulates the expression of NPY and POMC, the hypothalamic peptides controlling food intake and energy expenditure, probably by activation of the GABA<sub>A</sub> receptor in the arcuate nucleus (ARC). Furthermore, activation of the GABA<sub>A</sub> receptor in the paraventricular nucleus (PVN) influences TRH and CRH neurons which regulates the synthesis and secretion of triiodothyronine (T<sub>3</sub>) and corticosterone. The metabolic activities of T<sub>3</sub> in peripheral tissues includes the stimulation of lipolysis in adipose tissue through activation of hormone sensitive lipase (HSL), the activation of uncoupling protein 1 (UCP-1) mediated thermogenesis in brown adipose tissue, and the stimulation of oxidative capacity in liver and skeletal muscle by increasing mitochondrial biogenesis and activity, in part by increasing AMP-activated protein kinase (AMPK). Conversely, corticosterone down-regulates some metabolic pathways that are activated by T<sub>3</sub>. Thus, the modulation of PVN activity mediated by cardamom intake could reduce T<sub>3</sub> secretion but also corticosterone synthesis, increasing some of the thyroid-mediated metabolic actions in peripheral tissues. The regulation of the hypothalamic-pituitary-thyroid (HPT) and hypothalamic-pituitary-adrenal (HPA) axes by cardamom intake generates an “adjusted hormonal milieu”, reducing body fat by increased lipolysis and increasing oxygen consumption and energy expenditure through augmented mitochondrial activity in skeletal muscle and liver. Upwards arrow = upregulation, downwards arrow = downregulation.</p>
Full article ">
12 pages, 4066 KiB  
Article
Thyroid-Disrupting Effects of Cadmium and Mercury in Zebrafish Embryos/Larvae
by Liqiao Zhong, He Zhang, Luyin Wu, Huijun Ru, Nian Wei, Fan Yao, Zhaohui Ni, Xinbin Duan and Yunfeng Li
Water 2023, 15(1), 135; https://doi.org/10.3390/w15010135 - 30 Dec 2022
Viewed by 2135
Abstract
Cadmium (Cd2+) and mercury (Hg2+) are two kinds of non-essential heavy metals. Cd2+ and Hg2+ can cause thyroid disruption, but very few researchers have investigated the thyroid-disrupting effects of these metals on fish, specifically during their early [...] Read more.
Cadmium (Cd2+) and mercury (Hg2+) are two kinds of non-essential heavy metals. Cd2+ and Hg2+ can cause thyroid disruption, but very few researchers have investigated the thyroid-disrupting effects of these metals on fish, specifically during their early developmental transition stage from embryos to larvae. In this study, wild-type zebrafish embryos were exposed to varying concentrations (contents) of Cd2+ (0, 10, 100, and 1000 μg/L) and Hg2+ (0, 0.1, 1, and 10 μg/L) for 120 h. Thereafter, the thyroid hormone contents and transcriptional changes in the genes, including thyroid stimulating hormone-β (tshβ), thyroglobulin (tg), sodium-iodide symporter (nis), thyroid peroxidase (tpo), transthyretin (ttr), thyroid hormone receptor-α and -β (thrα, thrβ), types I and II iodothyronine deiodinase (dio1, dio2), and uridine diphosphate glucuronosyltransferase 1 family a, b (ugt1ab) associated with the hypothalamic-pituitary-thyroid (HPT) axis were measured. Results showed that zebrafish embryos/larvae malformation rates were significantly higher in the Cd2+ and Hg2+ groups. A significant increase in the thyroxine (T4) concentration and a decrease in the triiodothyronine (T3) concentration were observed in the Cd2+-exposed zebrafish embryos/larvae. On the other hand, the T4 and T3 concentrations were observed to be significantly increased after Hg2+ exposure. Additionally, changes were noted in the expression patterns of the HPT axis-linked genes after Cd2+ and Hg2+ exposure. Based on the results of the principal component analysis (PCA), it was concluded that Cd2+ exposure significantly affected the thyroid endocrine system at a concentration of 100 μg/L, whereas Hg2+ exposure led to a thyroid disruption at a low concentration of 0.1 μg/L. Thus, this study demonstrated that exposure to Cd2+ and Hg2+ metal ions induced developmental toxicity and led to thyroid disruption in zebrafish embryos/larvae. Full article
Show Figures

Figure 1

Figure 1
<p>Transcription levels of <span class="html-italic">tshβ</span> (<b>A</b>), <span class="html-italic">tg</span> (<b>B</b>), <span class="html-italic">nis</span> (<b>C</b>), <span class="html-italic">tpo</span> (<b>D</b>), <span class="html-italic">ttr</span> (<b>E</b>), <span class="html-italic">thrα</span> (<b>F</b>), <span class="html-italic">thrβ</span> (<b>G</b>), <span class="html-italic">dio1</span> (<b>H</b>), <span class="html-italic">dio2</span> (<b>I</b>), <span class="html-italic">ugt1ab</span> (<b>J</b>) and contents of T4 (<b>K</b>), T3 (<b>L</b>) in zebrafish embryos (2 hpf) that were treated with Cd<sup>2+</sup> (0, 10, 100, and 1000 μg/L) for 120 h. Data are shown as mean ± SD (n = 6). Different letters denote significant differences between groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2
<p>Transcription levels of <span class="html-italic">tshβ</span> (<b>A</b>), <span class="html-italic">tg</span> (<b>B</b>), <span class="html-italic">nis</span> (<b>C</b>), <span class="html-italic">tpo</span> (<b>D</b>), <span class="html-italic">ttr</span> (<b>E</b>), <span class="html-italic">thrα</span> (<b>F</b>), <span class="html-italic">thrβ</span> (<b>G</b>), <span class="html-italic">dio1</span> (<b>H</b>), <span class="html-italic">dio2</span> (<b>I</b>), <span class="html-italic">ugt1ab</span> (<b>J</b>) and contents of T4 (<b>K</b>), T3 (<b>L</b>) in zebrafish embryos (2 hpf) that were treated with Hg<sup>2+</sup> (0, 0.1, 1, and 10 μg/L) for 120 h. Data are shown as mean ± SD (n = 6). Different letters denote significant differences between groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Principal component analysis (PCA) of parameters in zebrafish embryos (2 hpf) that were treated with Cd<sup>2+</sup> (0, 10, 100, and 1000 μg/L) (<b>A</b>) and Hg<sup>2+</sup> (0, 0.1, 1, and 10 μg/L) (<b>B</b>) for 120 h.</p>
Full article ">Figure 4
<p>Heatmap of correlation coefficients between the thyroid hormones (THs, including T4 and T3) contents and the gene expression levels in the zebrafish embryos (2 hpf) that were treated with Cd<sup>2+</sup> (0, 10, 100, and 1000 μg/L) (<b>A</b>) and Hg<sup>2+</sup> (0, 0.1, 1, and 10 μg/L) (<b>B</b>) for 120 h. The scale indicates the level of positive (red) or negative (blue) correlation, and * indicates significance (* <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
12 pages, 2167 KiB  
Article
Copper and Zinc Treatments Alter the Thyroid Endocrine System in Zebrafish Embryos/Larvae
by Liqiao Zhong, He Zhang, Luyin Wu, Huijun Ru, Nian Wei, Fan Yao, Zhaohui Ni, Xinbin Duan and Yunfeng Li
Toxics 2022, 10(12), 756; https://doi.org/10.3390/toxics10120756 - 4 Dec 2022
Cited by 8 | Viewed by 2681
Abstract
Copper (Cu2+) and zinc (Zn2+) are two kinds of heavy metals essential to living organisms. Cu2+ and Zn2+ at excessive concentrations can cause adverse effects on animals, but little is known about the thyroid-disrupting effects of these [...] Read more.
Copper (Cu2+) and zinc (Zn2+) are two kinds of heavy metals essential to living organisms. Cu2+ and Zn2+ at excessive concentrations can cause adverse effects on animals, but little is known about the thyroid-disrupting effects of these metals in fish, especially in the early developmental transition stage from embryos to larvae. Wild-type zebrafish embryos were used to expose to Cu2+ (0, 1.5, 15, and 150 μg/L) and Zn2+ (0, 20, 200, and 2000 μg/L) for 120 h. Thyroid hormone contents and transcriptional changes of the genes connected with the hypothalamic-pituitary-thyroid (HPT) axis were measured. Results showed that zebrafish embryos/larvae malformation rates were significantly increased in the Cu2+ and Zn2+ groups. Remarkably elevated thyroxine (T4) concentrations and reduced triiodothyronine (T3) concentrations were observed in Cu2+ and Zn2+ exposure fish. And the expression patterns of genes connected with the HPT axis were changed after Cu2+ and Zn2+ treatment. Based on principal component analysis (PCA) results, Zn2+ caused significant effects on the thyroid endocrine system at 200 μg/L, while Cu2+ resulted in thyroid disruption as low as 1.5 μg/L. In short, our study demonstrated that exposure to Cu2+ and Zn2+ induced developmental toxicity and thyroid disruption to zebrafish embryos/larvae. Full article
(This article belongs to the Special Issue Environmental and Health Effects of Heavy Metal)
Show Figures

Figure 1

Figure 1
<p>Transcription levels of <span class="html-italic">tshβ</span> (<b>A</b>), <span class="html-italic">tg</span> (<b>B</b>), <span class="html-italic">nis</span> (<b>C</b>), <span class="html-italic">tpo</span> (<b>D</b>), <span class="html-italic">ttr</span> (<b>E</b>), <span class="html-italic">thrα</span> (<b>F</b>), <span class="html-italic">thrβ</span> (<b>G</b>), <span class="html-italic">dio1</span> (<b>H</b>), <span class="html-italic">dio2</span> (<b>I</b>), <span class="html-italic">ugt1ab</span> (<b>J</b>) and contents of T4 (<b>K</b>), T3 (<b>L</b>) in zebrafish embryos/larvae that were treated with Cu<sup>2+</sup> (0, 1.5, 15, and 150 μg/L) for 120 h. Data are shown as mean ± SD (<span class="html-italic">n</span> = 6). Different letters denote the significant differences between groups.</p>
Full article ">Figure 2
<p>Transcription levels of <span class="html-italic">tshβ</span> (<b>A</b>), <span class="html-italic">tg</span> (<b>B</b>), <span class="html-italic">nis</span> (<b>C</b>), <span class="html-italic">tpo</span> (<b>D</b>), <span class="html-italic">ttr</span> (<b>E</b>), <span class="html-italic">thrα</span> (<b>F</b>), <span class="html-italic">thrβ</span> (<b>G</b>), <span class="html-italic">dio1</span> (<b>H</b>), <span class="html-italic">dio2</span> (<b>I</b>), <span class="html-italic">ugt1ab</span> (<b>J</b>) and contents of T4 (<b>K</b>), T3 (<b>L</b>) in zebrafish embryos/larvae that were treated with Zn<sup>2+</sup> (0, 20, 200 and 2000 μg/L) for 120 h. Data are shown as mean ± SD (<span class="html-italic">n</span> = 6). Different letters denote the significant differences between groups.</p>
Full article ">Figure 3
<p>PCA of parameters in zebrafish embryos/larvae that were treated with Cu<sup>2+</sup> (0, 1.5, 15 and 150 μg/L) (<b>A</b>) and Zn<sup>2+</sup> (0, 20, 200 and 2000 μg/L) (<b>B</b>) for 120 h.</p>
Full article ">Figure 4
<p>Heatmap of correlation coefficients between the THs (T4 and T3) contents and the gene expression levels in the zebrafish embryos/larvae that were treated with Cu<sup>2+</sup> (0, 1.5, 15 and 150 μg/L) (<b>A</b>) and Zn<sup>2+</sup> (0, 20, 200 and 2000 μg/L) (<b>B</b>) for 120 h. The scale indicates the level of positive (red) or negative (blue) correlation, and * indicates significance (* <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
10 pages, 706 KiB  
Review
The Hypothalamic–Pituitary–Thyroid Axis Equivalent in Normal and Cancerous Oral Tissues: A Scoping Review
by Lisa Wu, Stephen Xu, Brian Yang, Jenny Yang, Claire Yee and Nicola Cirillo
Int. J. Mol. Sci. 2022, 23(22), 14096; https://doi.org/10.3390/ijms232214096 - 15 Nov 2022
Cited by 1 | Viewed by 2005
Abstract
The hypothalamic–pituitary–thyroid (HPT) axis is crucial in regulating thyroid hormone levels that contribute to the development and homeostasis of the human body. Current literature supports the presence of a local HPT axis equivalent within keratinocytes of the skin, with thyroid hormones playing a [...] Read more.
The hypothalamic–pituitary–thyroid (HPT) axis is crucial in regulating thyroid hormone levels that contribute to the development and homeostasis of the human body. Current literature supports the presence of a local HPT axis equivalent within keratinocytes of the skin, with thyroid hormones playing a potential role in cancer progression. However, this remains to be seen within oral tissue cells. An electronic search of Scopus and PubMed/Medline databases was conducted to identify all original publications that reported data on the production or effects of HPT axis components in normal or malignant cells of the oral cavity. The search identified 221 studies, of which 14 were eligible. Eight studies were retrospective analyses of clinical samples, one study involved both in vivo and in vitro experiments, and the remaining five studies were conducted in vitro using cell lines. The search identified evidence of effects of HPT components on oral cancer cells. However, there were limited data for the production of HPT axis components by oral tissues. We conclude that a possible role of the local HPT axis equivalent in the oral mucosa may not be established at present. The gaps in knowledge identified in this scoping review, particularly regarding the production of HPT components by oral tissues, warrant further investigation. Full article
(This article belongs to the Special Issue Advances in Molecular Mechanism of Head and Neck Cancer)
Show Figures

Figure 1

Figure 1
<p>Flowchart for study selection in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.</p>
Full article ">
Back to TopTop